- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
KNG1 Antibody KNG1/7422 recognizes kininogen 1, a plasma glycoprotein involved in blood coagulation, inflammatory signaling, and vascular homeostasis. Encoded by the KNG1 gene on chromosome 3, kininogen is synthesized primarily in the liver and secreted into circulation. Alternative splicing produces two major isoforms, high molecular weight kininogen (HMWK) and low molecular weight kininogen (LMWK), which share extensive N-terminal sequences but differ in their C-terminal domains. Both proteins serve as precursors of biologically active kinins and participate in pathways regulating vascular function.
High molecular weight kininogen is an essential component of the plasma contact activation system, where it facilitates interactions between prekallikrein, coagulation factor XI, and negatively charged surfaces. Activation of plasma kallikrein promotes cleavage of HMWK and release of bradykinin, a nine-amino-acid peptide that stimulates vasodilation, increases vascular permeability, and contributes to inflammatory responses. Low molecular weight kininogen also serves as a kinin precursor but lacks the specialized contact system binding regions found in HMWK. Both isoforms contain cystatin-like domains associated with protease regulation.
KNG1 has been extensively investigated in hereditary angioedema, thrombosis, vascular inflammation, and other disorders involving abnormal kallikrein-kinin signaling. Excessive bradykinin generation contributes to increased vascular permeability and tissue swelling in certain forms of hereditary angioedema. Experimental studies have also examined kininogen processing during endothelial dysfunction, ischemia-reperfusion injury, and inflammatory responses. The relationship between coagulation and innate immunity makes KNG1 an important subject in research examining interactions between plasma proteases and inflammatory mediators.
Beyond vascular disorders, altered kininogen abundance and proteolytic fragments have been investigated as potential biomarkers in cancer and inflammatory disease. Because KNG1 is primarily a circulating protein, tissue immunoreactivity may reflect local synthesis, vascular distribution, or extracellular deposition. NSJ Bioreagents offers clone KNG1/7422, a monoclonal antibody raised against human KNG1 amino acids 1-200, a region outside the mature bradykinin sequence. An KNG1 Antibody provides a useful tool for investigating kininogen expression, protein distribution, and molecular pathways connecting coagulation, inflammation, and vascular biology.
For additional research into kininogen expression, bradykinin generation, and vascular inflammatory pathways, explore our KNG1 Antibody page.
Optimal dilution of the KNG1 Antibody KNG1/7422 / Kininogen Monoclonal Antibody should be determined by the researcher.
A portion of amino acids 1-200 from human Kininogen 1 protein was used as the immunogen for the KNG1 Antibody KNG1/7422.
Aliquot the KNG1 Antibody KNG1/7422 and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Kininogen 1 antibody, Kininogen antibody, High Molecular Weight Kininogen antibody, Low Molecular Weight Kininogen antibody, HMWK antibody, LMWK antibody, Plasma Kininogen antibody, Bradykinin Precursor antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.